Home › High Blood Pressure › New York
High Blood Pressure clinical trials in New York
15 studies for High Blood Pressure are looking for participants at sites in New York.
Cities in New York
A Trial Evaluating Safety, Tolerability and Efficacy of CTX340 in Participants With Hypertension
- University of Rochester, Rochester
RecruitingPhase 1/2
Ages 18 to 75 · All sexes · Updated Nov 12, 2026 · NCT07758634Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
- Clinical Trial Site, New Windsor
- Clinical Trial Site, North Massapequa
- Clinical Trial Site, Poughkeepsie
- and 7 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT07181109EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Albany Med Health System - Washington Avenue Extension, Albany
- Velocity Clinical Research - Binghamton, Binghamton
- RCR - Buffalo, Buffalo
- and 7 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT07064473A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease
- North Shore University Hospital, Manhasset
- Mount Sinai Morningside, New York
- NewYork-Presbyterian Hospital/Columbia University Irving Medical Center, New York
- and 1 more
Recruiting
Ages 18 to 85 · All sexes · Updated Nov 10, 2026 · NCT07214376A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
- Research Site, Albany
- Research Site, Buffalo
- Research Site, New York
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 6, 2026 · NCT06742723A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
- Drug Trials America, Hartsdale
- NYC Research INC, Long Island City
- Rochester Clinical Research, LLC, Rochester
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 5, 2026 · NCT07794579A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension
- Retension Clinical Site, The Bronx
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Nov 4, 2026 · NCT07142356A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- Rochester Clinical Research - Buffalo, Buffalo
- CHEAR Center LLC, The Bronx
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT07783802Clevidipine for the Antihypertensive Treatment of Acute Intracerebral Hemorrhage
- Albany Medical Center, Albany
- Icahn School of Medicine at Mount Sinai, New York
RecruitingObservational study
Ages 18 to 100 · All sexes · Updated Oct 30, 2026 · NCT06402968Global Paradise System US Post Approval Study
- Albany Medical Center, Albany
- NewYork-Presbyterian Brooklyn Methodist Hospital, Brooklyn
- University at Buffalo, Buffalo
- and 3 more
RecruitingObservational study
Ages 18 and older · All sexes · Updated Oct 16, 2026 · NCT06297291BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
- Icahn School of Medicine at Mount Sinai, New York
Recruiting
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT06059638THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension
- St. Joseph, Liverpool
- Nyph/Cumc, New York
Recruiting
Ages 22 to 75 · All sexes · Updated Sep 24, 2026 · NCT06559891Innovative Approaches to Hypertension Management in High-Risk Emergency Department Populations
- Icahn School of Medicine at Mount Sinai, New York
Recruiting
Ages 18 and older · All sexes · Updated Apr 20, 2026 · NCT07539597Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension
- Vanda Investigative Site, Mount Kisco
- Vanda Investigative Site, Rochester
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Feb 27, 2026 · NCT07090161Partners in Control, Phase II: Using Remote Monitoring Technology With Community Health Workers to Support Hypertension Management for Latinx Patients
- NYU Langone Health, New York
Recruiting
Ages 18 and older · All sexes · Updated Dec 4, 2025 · NCT06730230From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.